The Most Impactful AI in Healthcare Isn’t Clinical, It’s Operational
There’s always going to be a new AI tool promising to save healthcare, optimize a…
The Most Impactful AI in Healthcare Isn’t Clinical, It’s Operational
There’s always going to be a new AI tool promising to save healthcare, optimize a workflow, or save someone a few minutes a day. But before we chase every emerging use case, we should tackle the biggest, most expensive part of the system: labor optimization. The post The Most Impactful AI in Healthcare Isn’t Clinical,…
What’s Missing from Your Tool Chest? How Health Plans Can Improve Star Ratings in Medicare Advantage
The pathway for health plans to achieve better Star ratings performance in their MA business depends on creating an ecosystem where providers are supported with the right tools and resources, incentives are properly aligned, and the member experience remains central to all initiatives. The post What’s Missing from Your Tool Chest? How Health Plans Can…
Exploring The Next Generation of Healthcare Benefits
[Sponsored] In this webinar, sponsored by Solera Health, executives will share how companies can make the most of healthcare benefits. The post Exploring The Next Generation of Healthcare Benefits appeared first on MedCity News.
Fighting a Health Insurance Denial? Here Are 7 Tips To Help
When Sally Nix found out that her health insurance company wouldn’t pay for an expensive, doctor-recommended treatment to ease her neurological pain, she prepared for battle. It took years, a chain of conflicting decisions, and a health insurer switch before she finally won approval. She started treatment in January and now channels time and energy…
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April. Her request for coverage had been denied, the letter said, because she’d had a body mass index of less than 35 when she started Zepbound. The 25-year-old who lives in New…
Listen: Limiting Benefits and Adding Restrictions, ‘MAHA’ Reshapes Food Aid
LISTEN: Carrot or the stick? Some nutritionists say incentives are the best way to improve the diets of low-income Americans on food aid, while the Trump administration seems focused on restrictions. KFF Health News senior correspondent Renuka Rayasam appeared on WAMU’s “Health Hub” on Sept. 3 to explain. The Trump administration is making historic changes…
KFF/The Washington Post Survey of Parents
The KFF-Washington Post partnership Survey of Parents explores experiences and views pertaining to childhood vaccines. The Survey of Parents also sheds light on school vaccination requirements, views on federal health agencies and policy changes, and the views of parents with children diagnosed with autism spectrum disorder. This poll comes as the Trump administration revamps federal…
Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic
Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences’ well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date. The post Startup Treeline Bio Emerges From the Shadows With…
NewDays Secures $7M To Expand Treatment for Cognitive Impairment, Dementia
NewDays’ $7 million seed round was led by General Catalyst and Madrona. The funds will be used to expand into additional states and grow its team. The post NewDays Secures $7M To Expand Treatment for Cognitive Impairment, Dementia appeared first on MedCity News.
Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy
That is the title of a paper published today in Current Medical Research and Opinion with co-authors Nadine Zawadzki, Moises Marin, Ivana Audhya, Lauren Sedita, Natasha Kulkarni and Alexa Klimchak. The abstract is below. ObjectivesQuantify caregiver risk preferences to inform the “value of hope” for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of…
